Nemaura Medical Inc.
Nemaura Medical Inc. (NMRD) Revenue
Annual & quarterly revenue history · segment & region breakdown
NMRD · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsNemaura Medical Inc. trailing twelve-month (TTM) revenue is $-0.00B, a decrease of 84.71% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-03-31 | $0.00B | -$0.00B | -84.71% |
| 2022-03-31 | $0.00B | +$0.00B | — |
| 2021-03-31 | $0.00B | +$0.00B | — |
| 2020-03-31 | $0.00B | +$0.00B | — |
| 2019-03-31 | $0.00B | +$0.00B | — |
| 2018-03-31 | $0.00B | +$0.00B | — |
| 2017-03-31 | $0.00B | +$0.00B | — |
| 2016-03-31 | $0.00B | +$0.00B | — |
| 2015-03-31 | $0.00B | +$0.00B | — |
| 2014-03-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Nemaura Medical Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Nemaura Medical Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Nemaura Medical Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NMRD revenue · 4 questionsNMRD's trailing twelve-month (TTM) revenue is $-0.00B. That is a decrease of 84.71% year-over-year from $0.00B in FY2023.
▸ Source: FMP · Nemaura Medical Inc. SEC filings · GAAP · Nemaura Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026